News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
310 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8747)
Month
January (2936)
February (2969)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (184)
2 (142)
5 (163)
6 (107)
7 (310)
8 (241)
9 (171)
12 (212)
13 (134)
14 (258)
15 (266)
16 (111)
19 (118)
20 (145)
21 (149)
22 (140)
23 (132)
26 (20)
27 (147)
28 (183)
29 (187)
30 (105)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Press Releases
FDA Approves New, Low-Dose Chlorthalidone for the Treatment of Hypertension in Adults: HemiClor™ (12.5 mg chlorthalidone)
May 7, 2025
·
4 min read
Press Releases
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025
May 7, 2025
·
1 min read
Press Releases
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025
May 7, 2025
·
25 min read
Press Releases
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
May 7, 2025
·
8 min read
Press Releases
Voyager Reports First Quarter 2025 Financial and Operating Results
May 7, 2025
·
14 min read
Press Releases
Standard BioTools Reports First Quarter 2025 Financial Results
May 7, 2025
·
16 min read
Press Releases
CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
May 7, 2025
·
19 min read
Press Releases
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
May 7, 2025
·
10 min read
Press Releases
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 7, 2025
·
1 min read
Press Releases
Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 7, 2025
·
11 min read
Previous
9 of 31
Next